US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

23.30

-0.6400-2.67%

Post-market: 23.520.2239+0.96%16:46 EDT

Volume:228.58K

Turnover:5.42M

Market Cap:1.29B

PE:-19.20

High:24.54

Open:24.36

Low:23.25

Close:23.94

52wk High:34.19

52wk Low:14.72

Shares:55.28M

Float Shares:17.65M

Volume Ratio:0.75

T/O Rate:1.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2134

EPS(LYR):-78.3394

ROE:-29.45%

ROA:-15.79%

PB:2.66

PE(LYR):-0.30

Loading ...

Overview Company News Filings

Aktis Oncology posts presentation on AKY-2519 clinical imaging, dosimetry data for B7-H3-targeted radioconjugate

Top Premarket Gainers

MT Newswires Live

Aktis Oncology (AKTS) Valuation Check After Recent Share Price Weakness And Lower Price To Book Ratio

Simply Wall St.

Aktis Oncology reports first-in-human AKY-2519 imaging data showing robust tumor uptake

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for Aky-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients With B7-H3 Expressing Tumors

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)

Aktis Oncology reports Q1 revenue $3.23M, consensus $1.85M

Aktis Oncology Q1 EPS $(0.38) Beats $(0.44) Estimate, Sales $3.227M Beat $1.750M Estimate

Benzinga Earnings

Aktis Oncology Q1 FY26 net loss widens to $18.3 million; revenue climbs to $3.2 million

Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026

Aktis Oncology to Present at the BofA Securities Health Care Conference

Aktis Oncology Initiated at Buy on Differentiated Radiopharmaceutical Platform and mCRPC Opportunity for AKY‑2519

Aktis Oncology posts presentation outlining AKY-2519 Phase 1b clinical development strategy

Aktis Oncology initiates clinical trial of AKY-25191

Aktis Oncology Initiates Phase 1B Clinical Trial for Aky-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

THOMSON REUTERS

Aktis Oncology Initiated at Outperform by William Blair

William Blair Initiates Aktis Oncology at Outperform

MT Newswires Live

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Aktis Oncology Board Shift And New Committee Draw Investor Focus On R&D

Simply Wall St.

Aktis Oncology director Glenn Gormley files initial beneficial ownership statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/AKTS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AKTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKTS\",,,,,undefined,":{"symbol":"AKTS","market":"US","secType":"STK","nameCN":"Aktis Oncology","latestPrice":23.3,"timestamp":1789156800000,"preClose":23.94,"halted":0,"volume":228577,"hourTrading":{"tag":"盘后","latestPrice":23.5239,"preClose":23.3,"latestTime":"16:46 EDT","volume":5596,"amount":130387.9192,"timestamp":1789159568906,"change":0.2239,"changeRate":0.009609,"amplitude":0.009609},"delay":0,"changeRate":-0.026733500417710967,"floatShares":17650000,"shares":55276000,"eps":-1.213352,"marketStatus":"Post-Mkt","change":-0.64,"latestTime":"09-11 17:37:17 EDT","open":24.36,"high":24.54,"low":23.25,"amount":5418470.35771,"amplitude":0.053885,"askPrice":23.62,"askSize":1,"bidPrice":21.04,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.213352,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1767934800000,"exchange":"NASDAQ","adjPreClose":23.94,"preHourTrading":{"tag":"盘前","latestPrice":24.87,"preClose":23.94,"latestTime":"09:25 EDT","volume":75,"amount":1820.88,"timestamp":1789133100053,"change":0.93,"changeRate":0.038847,"amplitude":0.036341},"postHourTrading":{"tag":"盘后","latestPrice":23.5239,"preClose":23.3,"latestTime":"16:46 EDT","volume":5596,"amount":130387.9192,"timestamp":1789159568906,"change":0.2239,"changeRate":0.009609,"amplitude":0.009609},"volumeRatio":0.751686,"impliedVol":1.9363,"impliedVolPercentile":0.9762},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKTS\",,,,,undefined,":{"symbol":"AKTS","floatShares":17650000,"roa":"-15.79%","roe":"-29.45%","lyrEps":-78.339422,"volumeRatio":0.751686,"shares":55276000,"dividePrice":0,"high":24.54,"amplitude":0.053885,"preClose":23.94,"low":23.25,"week52Low":14.72,"pbRate":"2.66","psRate":"128.02","week52High":34.1899,"institutionHeld":0,"latestPrice":23.3,"committee":0.980198,"eps":-1.213352,"divideRate":0,"volume":228577,"delay":0,"ttmEps":-1.213352,"open":24.36,"prevYearClose":18,"prevWeekClose":27.05,"prevMonthClose":25.91,"prevQuarterClose":32.23,"fiveDayClose":26.65,"twentyDayClose":23.79,"sixtyDayClose":22.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"AKTS","fiscalQuarterEnding":"2026/06","expectedEps":-0.44,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2026-05-11","symbol":"AKTS","fiscalQuarterEnding":"2026/03","expectedEps":-0.31,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":10,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKTS","date":"2026-09-10","current":-19.203001,"percent":0.115063,"low":-26.750774,"twenty":-9.421355,"median":-3.616315,"eighty":-0.80082,"high":-0.043077,"avg":-6.192993,"sd":6.978433,"marketCap":1338205145},"quantilePoints":[{"date":"2021-09-17","current":-11.520019,"twenty":-21.079286,"median":-9.454162,"eighty":-7.73598,"marketCap":508677978},{"date":"2021-09-24","current":-12.066929,"twenty":-21.079286,"median":-9.454162,"eighty":-7.73598,"marketCap":532827337},{"date":"2021-10-01","current":-11.264019,"twenty":-21.079286,"median":-9.454162,"eighty":-7.73598,"marketCap":497374023},{"date":"2021-10-08","current":-9.250925,"twenty":-21.079286,"median":-9.454162,"eighty":-7.73598,"marketCap":408483831},{"date":"2021-10-15","current":-10.181835,"twenty":-21.079286,"median":-9.45072,"eighty":-7.73598,"marketCap":449589122},{"date":"2021-10-22","current":-8.36656,"twenty":-21.079286,"median":-9.419783,"eighty":-7.73598,"marketCap":369433804},{"date":"2021-10-29","current":-8.75056,"twenty":-21.079286,"median":-9.408324,"eighty":-7.73598,"marketCap":386389737},{"date":"2021-11-05","current":-9.402873,"twenty":-20.759669,"median":-9.389596,"eighty":-7.73598,"marketCap":423646454},{"date":"2021-11-12","current":-9.114087,"twenty":-20.57358,"median":-9.362485,"eighty":-7.73598,"marketCap":410635199},{"date":"2021-11-19","current":-8.039803,"twenty":-20.027309,"median":-9.343737,"eighty":-7.73598,"marketCap":362233332},{"date":"2021-11-26","current":-7.762569,"twenty":-19.867687,"median":-9.335155,"eighty":-7.73598,"marketCap":349742527},{"date":"2021-12-03","current":-7.254305,"twenty":-19.560553,"median":-9.293728,"eighty":-7.722021,"marketCap":326842719},{"date":"2021-12-10","current":-7.831877,"twenty":-19.359275,"median":-9.270809,"eighty":-7.716481,"marketCap":352865228},{"date":"2021-12-17","current":-7.912737,"twenty":-18.898896,"median":-9.259349,"eighty":-7.716481,"marketCap":356508380},{"date":"2021-12-23","current":-8.351692,"twenty":-18.494398,"median":-9.24527,"eighty":-7.716481,"marketCap":376285487},{"date":"2021-12-31","current":-7.716363,"twenty":-17.912756,"median":-9.21168,"eighty":-7.713607,"marketCap":347660726},{"date":"2022-01-07","current":-6.907762,"twenty":-17.613727,"median":-9.186722,"eighty":-7.702013,"marketCap":311229213},{"date":"2022-01-14","current":-6.803799,"twenty":-17.00568,"median":-9.169719,"eighty":-7.683774,"marketCap":306545161},{"date":"2022-01-21","current":-5.879684,"twenty":-16.556856,"median":-9.158949,"eighty":-7.627055,"marketCap":264909146},{"date":"2022-01-28","current":-5.833478,"twenty":-16.173903,"median":-9.135241,"eighty":-7.590009,"marketCap":262827345},{"date":"2022-02-04","current":-6.109843,"twenty":-15.929357,"median":-9.113794,"eighty":-7.564559,"marketCap":295777500},{"date":"2022-02-11","current":-6.121137,"twenty":-15.57371,"median":-9.098915,"eighty":-7.534048,"marketCap":296324223},{"date":"2022-02-18","current":-6.911689,"twenty":-15.180573,"median":-9.089151,"eighty":-7.526663,"marketCap":334594879},{"date":"2022-02-25","current":-6.979451,"twenty":-15.112117,"median":-9.079406,"eighty":-7.499846,"marketCap":337875221},{"date":"2022-03-04","current":-6.584175,"twenty":-14.748762,"median":-9.060072,"eighty":-7.465505,"marketCap":318739893},{"date":"2022-03-11","current":-6.730992,"twenty":-14.443342,"median":-9.048835,"eighty":-7.443792,"marketCap":325847301},{"date":"2022-03-18","current":-7.137562,"twenty":-13.95631,"median":-9.037333,"eighty":-7.401498,"marketCap":345529353},{"date":"2022-03-25","current":-7.521544,"twenty":-13.806802,"median":-9.01401,"eighty":-7.386226,"marketCap":364117957},{"date":"2022-04-01","current":-7.386021,"twenty":-13.521378,"median":-8.991446,"eighty":-7.38341,"marketCap":357557273},{"date":"2022-04-08","current":-6.66323,"twenty":-13.257789,"median":-8.951116,"eighty":-7.368007,"marketCap":322566959},{"date":"2022-04-14","current":-6.279247,"twenty":-12.980549,"median":-8.922367,"eighty":-7.333618,"marketCap":303978354},{"date":"2022-04-22","current":-5.364465,"twenty":-12.741048,"median":-8.88008,"eighty":-7.276954,"marketCap":259693738},{"date":"2022-04-29","current":-5.014363,"twenty":-12.447377,"median":-8.860163,"eighty":-7.255678,"marketCap":242745305},{"date":"2022-05-06","current":-4.536581,"twenty":-12.310619,"median":-8.837093,"eighty":-7.229669,"marketCap":240080403},{"date":"2022-05-13","current":-4.11359,"twenty":-12.234973,"median":-8.828667,"eighty":-7.204199,"marketCap":217695284},{"date":"2022-05-20","current":-3.891519,"twenty":-12.173931,"median":-8.790076,"eighty":-7.175711,"marketCap":205943096},{"date":"2022-05-27","current":-4.494282,"twenty":-12.066929,"median":-8.771206,"eighty":-7.159584,"marketCap":237841891},{"date":"2022-06-03","current":-4.388534,"twenty":-11.917316,"median":-8.741719,"eighty":-7.136986,"marketCap":232245611},{"date":"2022-06-10","current":-4.09244,"twenty":-11.801443,"median":-8.728611,"eighty":-7.074177,"marketCap":216576028},{"date":"2022-06-17","current":-3.722323,"twenty":-11.667488,"median":-8.701449,"eighty":-7.026055,"marketCap":196989048},{"date":"2022-06-24","current":-4.557731,"twenty":-11.604443,"median":-8.681107,"eighty":-6.993393,"marketCap":241199659},{"date":"2022-07-01","current":-3.817496,"twenty":-11.522894,"median":-8.646459,"eighty":-6.974612,"marketCap":202025700},{"date":"2022-07-08","current":-3.880945,"twenty":-11.440168,"median":-8.610924,"eighty":-6.945216,"marketCap":205383468},{"date":"2022-07-15","current":-3.796346,"twenty":-11.361316,"median":-8.599537,"eighty":-6.91877,"marketCap":200906444},{"date":"2022-07-22","current":-4.35681,"twenty":-11.304911,"median":-8.574152,"eighty":-6.895583,"marketCap":230566727},{"date":"2022-07-29","current":-4.526006,"twenty":-11.254598,"median":-8.552498,"eighty":-6.843928,"marketCap":239520775},{"date":"2022-08-05","current":-5.04417,"twenty":-11.170669,"median":-8.539637,"eighty":-6.814324,"marketCap":266942546},{"date":"2022-08-12","current":-5.53061,"twenty":-11.083944,"median":-8.5255,"eighty":-6.76848,"marketCap":292685433},{"date":"2022-08-19","current":-5.033596,"twenty":-10.991704,"median":-8.511173,"eighty":-6.754109,"marketCap":266382918},{"date":"2022-08-26","current":-4.853824,"twenty":-10.953692,"median":-8.494833,"eighty":-6.711458,"marketCap":256869242},{"date":"2022-09-02","current":-4.33566,"twenty":-10.854456,"median":-8.48461,"eighty":-6.67125,"marketCap":229447471},{"date":"2022-09-09","current":-4.684628,"twenty":-10.775987,"median":-8.475333,"eighty":-6.640205,"marketCap":247915195},{"date":"2022-09-16","current":-3.616315,"twenty":-10.702461,"median":-8.458285,"eighty":-6.595468,"marketCap":213460242},{"date":"2022-09-23","current":-2.908565,"twenty":-10.640754,"median":-8.43675,"eighty":-6.547402,"marketCap":171683841},{"date":"2022-09-30","current":-2.883968,"twenty":-10.568347,"median":-8.423889,"eighty":-6.504146,"marketCap":170232000},{"date":"2022-10-07","current":-2.748024,"twenty":-10.517463,"median":-8.412138,"eighty":-6.449797,"marketCap":162207596},{"date":"2022-10-14","current":-2.34019,"twenty":-10.45609,"median":-8.36656,"eighty":-6.366255,"marketCap":138134384},{"date":"2022-10-21","current":-2.388741,"twenty":-10.422458,"median":-8.360083,"eighty":-6.279247,"marketCap":141000243},{"date":"2022-10-28","current":-3.184989,"twenty":-10.356303,"median":-8.346724,"eighty":-6.237995,"marketCap":188000324},{"date":"2022-11-04","current":-3.097596,"twenty":-10.331232,"median":-8.32885,"eighty":-6.137612,"marketCap":182841778},{"date":"2022-11-11","current":-3.495719,"twenty":-10.297532,"median":-8.307436,"eighty":-6.101111,"marketCap":206341819},{"date":"2022-11-18","current":-3.169808,"twenty":-10.19068,"median":-8.297617,"eighty":-6.081462,"marketCap":206890225},{"date":"2022-11-25","current":-3.205028,"twenty":-10.182112,"median":-8.280162,"eighty":-6.07343,"marketCap":209189005},{"date":"2022-12-02","current":-3.293079,"twenty":-10.149755,"median":-8.255972,"eighty":-6.040455,"marketCap":214935956},{"date":"2022-12-09","current":-3.046538,"twenty":-10.08458,"median":-8.235118,"eighty":-5.983545,"marketCap":198844494},{"date":"2022-12-16","current":-2.782387,"twenty":-10.000527,"median":-8.214764,"eighty":-5.970789,"marketCap":181603642},{"date":"2022-12-23","current":-2.183646,"twenty":-9.982749,"median":-8.198382,"eighty":-5.943836,"marketCap":142524377},{"date":"2022-12-30","current":-2.483017,"twenty":-9.914504,"median":-8.183095,"eighty":-5.8844,"marketCap":162064009},{"date":"2023-01-06","current":-2.546452,"twenty":-9.872453,"median":-8.177938,"eighty":-5.844777,"marketCap":166204393},{"date":"2023-01-13","current":-3.30592,"twenty":-9.848372,"median":-8.146917,"eighty":-5.824514,"marketCap":215774124},{"date":"2023-01-20","current":-3.235112,"twenty":-9.808182,"median":-8.129989,"eighty":-5.80271,"marketCap":211152504},{"date":"2023-01-27","current":-3.891865,"twenty":-9.780914,"median":-8.118308,"eighty":-5.768603,"marketCap":254018159},{"date":"2023-02-03","current":-4.736016,"twenty":-9.780914,"median":-8.099806,"eighty":-5.739629,"marketCap":309115055},{"date":"2023-02-10","current":-5.065903,"twenty":-9.780914,"median":-8.086009,"eighty":-5.647592,"marketCap":309830599},{"date":"2023-02-17","current":-4.545273,"twenty":-9.780914,"median":-8.068573,"eighty":-5.61525,"marketCap":277988886},{"date":"2023-02-24","current":-4.200136,"twenty":-9.767554,"median":-8.05705,"eighty":-5.572052,"marketCap":256880335},{"date":"2023-03-03","current":-4.270334,"twenty":-9.767554,"median":-8.048222,"eighty":-5.540035,"marketCap":261173600},{"date":"2023-03-10","current":-3.732155,"twenty":-9.767554,"median":-8.036541,"eighty":-5.497936,"marketCap":228258571},{"date":"2023-03-17","current":-3.416267,"twenty":-9.767554,"median":-8.0167,"eighty":-5.470061,"marketCap":208938880},{"date":"2023-03-24","current":-3.381168,"twenty":-9.735938,"median":-7.970495,"eighty":-5.409362,"marketCap":206792247},{"date":"2023-03-31","current":-3.60346,"twenty":-9.722138,"median":-7.958996,"eighty":-5.282256,"marketCap":220387585},{"date":"2023-04-06","current":-3.287572,"twenty":-9.722138,"median":-7.945279,"eighty":-5.176918,"marketCap":201067894},{"date":"2023-04-14","current":-3.895948,"twenty":-9.723901,"median":-7.943093,"eighty":-5.150642,"marketCap":238276188},{"date":"2023-04-21","current":-3.931047,"twenty":-9.723901,"median":-7.921737,"eighty":-5.082633,"marketCap":240422820},{"date":"2023-04-28","current":-3.474765,"twenty":-9.723901,"median":-7.919731,"eighty":-5.019558,"marketCap":212516600},{"date":"2023-05-05","current":-3.193976,"twenty":-9.723901,"median":-7.901186,"eighty":-4.965756,"marketCap":195343542},{"date":"2023-05-12","current":-3.1382,"twenty":-9.718789,"median":-7.880607,"eighty":-4.931564,"marketCap":194627997},{"date":"2023-05-19","current":-3.615506,"twenty":-9.717733,"median":-7.878083,"eighty":-4.911402,"marketCap":224233666},{"date":"2023-05-26","current":-3.280523,"twenty":-9.717733,"median":-7.860856,"eighty":-4.828445,"marketCap":203458023},{"date":"2023-05-31","current":-3.650159,"twenty":-9.717733,"median":-7.860352,"eighty":-4.792139,"marketCap":226382870},{"date":"2023-06-09","current":-3.96204,"twenty":-9.718261,"median":-7.829939,"eighty":-4.734549,"marketCap":245725711},{"date":"2023-06-16","current":-3.580852,"twenty":-9.719846,"median":-7.808675,"eighty":-4.726082,"marketCap":222084461},{"date":"2023-06-23","current":-3.465341,"twenty":-9.683831,"median":-7.783267,"eighty":-4.652904,"marketCap":214920447},{"date":"2023-06-30","current":-3.580852,"twenty":-9.690611,"median":-7.767273,"eighty":-4.621179,"marketCap":222084461},{"date":"2023-07-07","current":-3.188114,"twenty":-9.675131,"median":-7.749821,"eighty":-4.550834,"marketCap":197726811},{"date":"2023-07-14","current":-3.211216,"twenty":-9.645898,"median":-7.730374,"eighty":-4.526006,"marketCap":199159614},{"date":"2023-07-21","current":-2.853131,"twenty":-9.593766,"median":-7.709472,"eighty":-4.482913,"marketCap":176951168},{"date":"2023-07-28","current":-2.668313,"twenty":-9.546258,"median":-7.687728,"eighty":-4.386419,"marketCap":165488744},{"date":"2023-08-04","current":-2.633659,"twenty":-9.51146,"median":-7.626081,"eighty":-4.339557,"marketCap":163339539},{"date":"2023-08-11","current":-2.229369,"twenty":-9.489388,"median":-7.589855,"eighty":-4.310281,"marketCap":138265487},{"date":"2023-08-18","current":-2.090756,"twenty":-9.488541,"median":-7.569514,"eighty":-4.239388,"marketCap":129668669},{"date":"2023-08-25","current":-2.125409,"twenty":-9.452954,"median":-7.534257,"eighty":-4.207861,"marketCap":131817874},{"date":"2023-09-01","current":-1.744222,"twenty":-9.425606,"median":-7.52475,"eighty":-4.138144,"marketCap":108176624},{"date":"2023-09-08","current":-1.183912,"twenty":-9.425606,"median":-7.507962,"eighty":-4.090325,"marketCap":75245900},{"date":"2023-09-15","current":-1.047806,"twenty":-9.425606,"median":-7.470845,"eighty":-4.039566,"marketCap":66595382},{"date":"2023-09-22","current":-0.880002,"twenty":-9.425606,"median":-7.452533,"eighty":-4.007842,"marketCap":55930281},{"date":"2023-09-29","current":-0.904023,"twenty":-9.425606,"median":-7.415266,"eighty":-3.989762,"marketCap":57456968},{"date":"2023-10-06","current":-0.921213,"twenty":-9.425606,"median":-7.390019,"eighty":-3.910554,"marketCap":58549526},{"date":"2023-10-13","current":-0.881482,"twenty":-9.425606,"median":-7.390019,"eighty":-3.889404,"marketCap":56024342},{"date":"2023-10-20","current":-0.797011,"twenty":-9.425606,"median":-7.390019,"eighty":-3.838326,"marketCap":50655614},{"date":"2023-10-27","current":-0.570464,"twenty":-9.425883,"median":-7.394085,"eighty":-3.823891,"marketCap":36257003},{"date":"2023-11-03","current":-0.625109,"twenty":-9.425883,"median":-7.394085,"eighty":-3.809036,"marketCap":39730035},{"date":"2023-11-10","current":-0.552363,"twenty":-9.425883,"median":-7.394085,"eighty":-3.750588,"marketCap":35106562},{"date":"2023-11-17","current":-0.772023,"twenty":-9.425883,"median":-7.394085,"eighty":-3.724062,"marketCap":49868795},{"date":"2023-11-24","current":-0.69684,"twenty":-9.425883,"median":-7.394085,"eighty":-3.711095,"marketCap":45012387},{"date":"2023-12-01","current":-0.639612,"twenty":-9.425883,"median":-7.394085,"eighty":-3.696364,"marketCap":41315717},{"date":"2023-12-08","current":-0.639612,"twenty":-9.425791,"median":-7.393795,"eighty":-3.650199,"marketCap":41315717},{"date":"2023-12-15","current":-0.93518,"twenty":-9.425791,"median":-7.393795,"eighty":-3.626975,"marketCap":60407928},{"date":"2023-12-22","current":-0.82162,"twenty":-9.425791,"median":-7.393795,"eighty":-3.606093,"marketCap":53072576},{"date":"2023-12-29","current":-1.014738,"twenty":-9.425883,"median":-7.394085,"eighty":-3.597033,"marketCap":65547023},{"date":"2024-01-05","current":-0.83273,"twenty":-9.425976,"median":-7.398718,"eighty":-3.580852,"marketCap":53790164},{"date":"2024-01-12","current":-0.789864,"twenty":-9.425976,"median":-7.390019,"eighty":-3.499994,"marketCap":51021286},{"date":"2024-01-19","current":-0.785488,"twenty":-9.431311,"median":-7.383661,"eighty":-3.47288,"marketCap":50738600},{"date":"2024-01-26","current":-0.777439,"twenty":-9.425976,"median":-7.343047,"eighty":-3.427933,"marketCap":50218657},{"date":"2024-02-02","current":-0.844744,"twenty":-9.425976,"median":-7.288956,"eighty":-3.392868,"marketCap":54566219},{"date":"2024-02-09","current":-1.004869,"twenty":-9.425976,"median":-7.254991,"eighty":-3.381168,"marketCap":64909545},{"date":"2024-02-16","current":-1.048057,"twenty":-9.425976,"median":-7.226143,"eighty":-3.34983,"marketCap":72473173},{"date":"2024-02-23","current":-1.056898,"twenty":-9.425976,"median":-7.201353,"eighty":-3.326727,"marketCap":73084511},{"date":"2024-03-01","current":-0.886642,"twenty":-9.425883,"median":-7.176278,"eighty":-3.300142,"marketCap":61311318},{"date":"2024-03-08","current":-0.87994,"twenty":-9.425883,"median":-7.161894,"eighty":-3.276802,"marketCap":60847884},{"date":"2024-03-15","current":-0.809214,"twenty":-9.425883,"median":-7.137562,"eighty":-3.24201,"marketCap":55957178},{"date":"2024-03-22","current":-0.874807,"twenty":-9.425883,"median":-7.07847,"eighty":-3.229094,"marketCap":60492914},{"date":"2024-03-28","current":-0.831602,"twenty":-9.425883,"median":-7.046379,"eighty":-3.211216,"marketCap":57505244},{"date":"2024-04-05","current":-0.849853,"twenty":-9.425976,"median":-7.016366,"eighty":-3.193976,"marketCap":58767362},{"date":"2024-04-12","current":-0.855557,"twenty":-9.425976,"median":-6.979451,"eighty":-3.176563,"marketCap":59161774},{"date":"2024-04-19","current":-0.728649,"twenty":-9.425976,"median":-6.925388,"eighty":-3.1382,"marketCap":50386111},{"date":"2024-04-26","current":-0.80679,"twenty":-9.425883,"median":-6.911689,"eighty":-3.101472,"marketCap":55789553},{"date":"2024-05-03","current":-0.855557,"twenty":-9.425883,"median":-6.855221,"eighty":-3.084899,"marketCap":59161774},{"date":"2024-05-10","current":-0.801942,"twenty":-9.424367,"median":-6.82134,"eighty":-3.056996,"marketCap":55454303},{"date":"2024-05-17","current":-0.51046,"twenty":-9.424367,"median":-6.764872,"eighty":-3.029075,"marketCap":39260507},{"date":"2024-05-24","current":-0.297791,"twenty":-9.424367,"median":-6.748882,"eighty":-2.98725,"marketCap":22903715},{"date":"2024-05-31","current":-0.272384,"twenty":-9.424367,"median":-6.679306,"eighty":-2.962779,"marketCap":20949585},{"date":"2024-06-07","current":-0.2633,"twenty":-9.424367,"median":-6.649488,"eighty":-2.888887,"marketCap":20250901},{"date":"2024-06-14","current":-0.198717,"twenty":-9.425513,"median":-6.595468,"eighty":-2.853131,"marketCap":15283699},{"date":"2024-06-21","current":-0.174729,"twenty":-9.425606,"median":-6.550294,"eighty":-2.755792,"marketCap":13438738},{"date":"2024-06-28","current":-0.210924,"twenty":-9.425883,"median":-6.589822,"eighty":-2.716644,"marketCap":16222555},{"date":"2024-07-05","current":-0.180264,"twenty":-9.425883,"median":-6.589822,"eighty":-2.668313,"marketCap":13864498},{"date":"2024-07-12","current":-0.181116,"twenty":-9.425883,"median":-6.589822,"eighty":-2.611619,"marketCap":13930000},{"date":"2024-07-15","current":-0.188213,"twenty":-9.425883,"median":-6.589822,"eighty":-2.591763,"marketCap":14475846},{"date":"2024-08-02","current":-0.161102,"twenty":-9.454162,"median":-6.66323,"eighty":-2.528122,"marketCap":12390713},{"date":"2024-08-09","current":-0.116817,"twenty":-9.454162,"median":-6.66323,"eighty":-2.484714,"marketCap":8984631},{"date":"2024-08-16","current":-0.126611,"twenty":-9.454162,"median":-6.66323,"eighty":-2.421521,"marketCap":9737899},{"date":"2024-08-23","current":-0.132856,"twenty":-9.454162,"median":-6.66323,"eighty":-2.380665,"marketCap":10218244},{"date":"2024-08-30","current":-0.120649,"twenty":-9.454162,"median":-6.595468,"eighty":-2.268939,"marketCap":9279388},{"date":"2024-09-06","current":-0.10021,"twenty":-9.454162,"median":-6.515013,"eighty":-2.220128,"marketCap":7707351},{"date":"2024-09-13","current":-0.086726,"twenty":-9.454162,"median":-6.324422,"eighty":-2.120528,"marketCap":6670243},{"date":"2024-09-20","current":-0.096661,"twenty":-9.454162,"median":-6.121137,"eighty":-2.007587,"marketCap":7434428},{"date":"2024-09-27","current":-0.106597,"twenty":-9.454162,"median":-6.077936,"eighty":-1.751153,"marketCap":8198613},{"date":"2024-10-04","current":-0.109436,"twenty":-9.454162,"median":-5.985613,"eighty":-1.183941,"marketCap":8416951},{"date":"2024-10-11","current":-0.069126,"twenty":-9.454162,"median":-5.833478,"eighty":-1.109908,"marketCap":11609777},{"date":"2024-10-18","current":-0.061395,"twenty":-9.454162,"median":-5.635511,"eighty":-1.044715,"marketCap":10311214},{"date":"2024-10-25","current":-0.052742,"twenty":-9.454162,"median":-5.499988,"eighty":-0.979068,"marketCap":8858059},{"date":"2024-10-31","current":-0.056424,"twenty":-9.454162,"median":-5.414288,"eighty":-0.960558,"marketCap":9476423},{"date":"2024-11-08","current":-0.048048,"twenty":-9.454162,"median":-5.171068,"eighty":-0.930775,"marketCap":8069645},{"date":"2024-11-15","current":-0.049245,"twenty":-9.454162,"median":-5.123106,"eighty":-0.923403,"marketCap":8270614},{"date":"2024-11-22","current":-0.104637,"twenty":-9.454162,"median":-5.038883,"eighty":-0.901295,"marketCap":16139291},{"date":"2024-11-29","current":-0.101329,"twenty":-9.454162,"median":-4.986009,"eighty":-0.890153,"marketCap":15629141},{"date":"2024-12-06","current":-0.095216,"twenty":-9.454162,"median":-4.945643,"eighty":-0.881778,"marketCap":14686137},{"date":"2024-12-13","current":-0.076373,"twenty":-9.454162,"median":-4.913603,"eighty":-0.875055,"marketCap":11779827},{"date":"2024-12-16","current":-0.068355,"twenty":-9.454162,"median":-4.905197,"eighty":-0.871307,"marketCap":10543100},{"date":"2026-01-16","current":-24.553389,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1079858056},{"date":"2026-01-23","current":-26.750774,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1176499049},{"date":"2026-01-30","current":-23.454697,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1031537559},{"date":"2026-02-06","current":-23.371101,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1027861000},{"date":"2026-02-13","current":-21.376735,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":940148794},{"date":"2026-02-20","current":-21.985793,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":966935156},{"date":"2026-02-27","current":-23.442754,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1031012336},{"date":"2026-03-06","current":-24.529505,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1078807610},{"date":"2026-03-13","current":-21.842485,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":960632482},{"date":"2026-03-20","current":-21.472273,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":944350576},{"date":"2026-03-27","current":-21.04235,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":925442555},{"date":"2026-04-02","current":-14.805375,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":943561354},{"date":"2026-04-10","current":-15.325775,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":976726955},{"date":"2026-04-17","current":-16.132395,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1028133637},{"date":"2026-04-24","current":-19.150714,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1220494124},{"date":"2026-05-01","current":-16.262495,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1036425037},{"date":"2026-05-08","current":-16.340554,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1041399877},{"date":"2026-05-15","current":-16.071182,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1077910216},{"date":"2026-05-22","current":-15.758,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1056904786},{"date":"2026-05-29","current":-16.837653,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1129318242},{"date":"2026-06-05","current":-16.392605,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1099468420},{"date":"2026-06-12","current":-16.038215,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1075699118},{"date":"2026-06-18","current":-19.392559,"twenty":-9.412114,"median":-3.616575,"eighty":-0.801381,"marketCap":1300678327},{"date":"2026-06-26","current":-25.672682,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1721892474},{"date":"2026-07-02","current":-25.4584,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1707520337},{"date":"2026-07-10","current":-23.422717,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1570985043},{"date":"2026-07-17","current":-20.620562,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1383041723},{"date":"2026-07-24","current":-19.788157,"twenty":-9.393294,"median":-3.616445,"eighty":-0.801101,"marketCap":1327211502},{"date":"2026-07-31","current":-18.955753,"twenty":-9.373672,"median":-3.616315,"eighty":-0.80082,"marketCap":1271381281},{"date":"2026-08-07","current":-19.318384,"twenty":-9.373672,"median":-3.616315,"eighty":-0.80082,"marketCap":1295703357},{"date":"2026-08-14","current":-19.728167,"twenty":-9.373672,"median":-3.616315,"eighty":-0.80082,"marketCap":1323187881},{"date":"2026-08-21","current":-18.250861,"twenty":-9.421355,"median":-3.616315,"eighty":-0.80082,"marketCap":1334867976},{"date":"2026-08-28","current":-19.908648,"twenty":-9.421355,"median":-3.616315,"eighty":-0.80082,"marketCap":1456118483},{"date":"2026-09-04","current":-20.26606,"twenty":-9.421355,"median":-3.616315,"eighty":-0.80082,"marketCap":1482259648},{"date":"2026-09-10","current":-18.296488,"twenty":-9.421355,"median":-3.616315,"eighty":-0.80082,"marketCap":1338205145}],"updateTime":1789162637330},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AKTS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638586500","title":"Aktis Oncology posts presentation on AKY-2519 clinical imaging, dosimetry data for B7-H3-targeted radioconjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2638586500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638586500?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:14","pubTimestamp":1779884043,"startTime":"0","endTime":"0","summary":"Aktis Oncology presented first-in-human imaging, biodistribution, and dosimetry for B7-H3 radioconjugate AKY-2519 across advanced solid tumors.Early dataset showed no reported adverse events or infusion-related reactions, supporting continued clinical development.Dosimetry suggested high tumor absorbed doses with low predicted exposure to critical organs, indicating a potentially wide therapeutic index for actinium-225 therapy in mCRPC.Imaging in 34 patients showed lesion detection consistent with PSMA-11 in prostate cancer, with uptake also seen in lung cancers and colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief on May 27, 2026, and i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3qhhhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS","BK4148","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637631645","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637631645","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637631645?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:18","pubTimestamp":1779448694,"startTime":"0","endTime":"0","summary":"PicoCELA  shares were up 172% in Friday premarket activity, extending Thursday's 60% rally.Leifras  stock was 113% higher after the company agreed to acquire Tokai Sports.Akari Therapeutics  shares were up 64% after the company reported positive preclinical data for its AKTX-101 investigational drug candidate.MetaVia  stock was 40% higher following a muted session.HCW Biologics  shares were up 25% after the company priced a private securities offering.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK7093","LFS","HCWB","BK4539","AKTX","PCLA","BK4020","MTVA","AKTS","BK4007","BK4148","BK4204","LFS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637949783","title":"Aktis Oncology (AKTS) Valuation Check After Recent Share Price Weakness And Lower Price To Book Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2637949783","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637949783?lang=en_us&edition=fundamental","pubTime":"2026-05-22 15:38","pubTimestamp":1779435488,"startTime":"0","endTime":"0","summary":"Aktis Oncology stock: key recent moves\nAktis Oncology (AKTS) has drawn attention after recent trading left the stock at a last close of $19.12, with short term returns mixed and year to date performance currently showing a double digit decline.\nSee our latest analysis for Aktis Oncology.\nRecent trading shows momentum fading, with a 7 day share price return of 1.95% lower and a 30 day share price return of 6.73% lower, while the year to date share price return is 14.64% lower from the current...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-akts/aktis-oncology/news/aktis-oncology-akts-valuation-check-after-recent-share-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-akts/aktis-oncology/news/aktis-oncology-akts-valuation-check-after-recent-share-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357765","title":"Aktis Oncology reports first-in-human AKY-2519 imaging data showing robust tumor uptake","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357765","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357765?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:39","pubTimestamp":1779399551,"startTime":"0","endTime":"0","summary":"Aktis Oncology released first-in-human imaging and dosimetry findings for its B7-H3-targeted radioconjugate AKY-2519, with data scheduled for presentation at the 2026 ASCO Annual Meeting on May 30.The readout showed strong tumor uptake with limited exposure in normal tissues across assessments in metastatic castration-resistant prostate cancer and a broader set of advanced solid tumors.The profile supported continued clinical development, including an ongoing Phase 1b study in mCRPC that includes PLUVICTO-nave and PLUVICTO-experienced patients, with preliminary data expected in 2027.A second Phase 1b study in other B7-H3-expressing solid tumors is planned to start in the second half of 2026, expanding the program beyond prostate cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL1ycsH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4148","AKTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637977357","title":"Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for Aky-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients With B7-H3 Expressing Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2637977357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637977357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:21","pubTimestamp":1779398468,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA8QPGQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTS","BK4148","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634255803","title":"Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634255803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634255803?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:50","pubTimestamp":1778536214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aktis-oncology-inc-akts-metagenomi-inc-mgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aktis-oncology-inc-akts-metagenomi-inc-mgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XBI","LU0029874061.USD","BK4148","BK4139","BLSG","MGX","BK4585","BLSX","LU0128526141.USD","BK4588","BK4112","BK4137","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253271","title":"Aktis Oncology reports Q1 revenue $3.23M, consensus $1.85M","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253271","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253271?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:36","pubTimestamp":1778535418,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents and marketable securities were $538.5M as of March 31, compared to $226.8M as of December 31, 2025. “We continue to build mo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aktis-oncology-reports-q1-revenue-3-23m-consensus-1-85m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aktis-oncology-reports-q1-revenue-3-23m-consensus-1-85m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253459","title":"Aktis Oncology Q1 EPS $(0.38) Beats $(0.44) Estimate, Sales $3.227M Beat $1.750M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253459","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253459?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:35","pubTimestamp":1778535353,"startTime":"0","endTime":"0","summary":"Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.44) by 13.64 percent. This is a 97.96 percent increase over losses of $(18.60) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52472867/aktis-oncology-q1-eps-0-38-beats-0-44-estimate-sales-3-227m-beat-1-750m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aktis Oncology Q1 EPS $(0.38) Beats $(0.44) Estimate, Sales $3.227M Beat $1.750M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232223","title":"Aktis Oncology Q1 FY26 net loss widens to $18.3 million; revenue climbs to $3.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232223?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:06","pubTimestamp":1778529974,"startTime":"0","endTime":"0","summary":"Aktis Oncology posted a net loss of $18.3 million for first-quarter 2026, widening from a $15 million loss a year earlier.Collaboration revenue rose to $3.2 million from $1.4 million, on continued advancement of its research collaboration with Eli Lilly.R&D expenses climbed to $20 million from $15.9 million, while G&A costs increased to $5.9 million from $3.7 million.Cash, cash equivalents and marketable securities totaled $538.5 million at March 31, up from $226.8 million at year-end 2025, following gross IPO proceeds of about $365.4 million; cash runway expected into 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data G","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLqKvZg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1232071149.USD","LU2168564065.EUR","LU2089284900.SGD","LU2361044865.SGD","LU1145028129.USD","SG9999018865.SGD","LU0432979614.USD","SGXZ51526630.SGD","LU2461242641.AUD","IE00BJLML261.HKD","LU2271345857.HKD","LU2756315318.SGD","LU0323591593.USD","SG9999015945.SGD","SG9999001176.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE0004445239.USD","IE00BFSS7M15.SGD","LU2471134523.USD","LU0061475181.USD","LU0097036916.USD","LU0006306889.USD","SG9999015978.USD","LU1814569148.SGD","LU0238689110.USD","LU2112291526.USD","LU2750360997.AUD","LU2265009873.SGD","LU2168564149.EUR","LU0289739699.SGD","LU2087625088.SGD","BK4516","LU2237443895.HKD","SG9999018857.SGD","LU1280957306.USD","LU2756315664.SGD","IE00B775H168.HKD","LU0708995401.HKD","LU1868837136.USD","BK4139","BK4534","LU1035775433.USD","SG9999017495.SGD","LU2023251221.USD","SG9999014906.USD","LU0640476718.USD","LU0786609619.USD","LU0096364046.USD","LU2237443622.USD","LU2491050154.USD","LU1868836591.USD","LU2746668974.SGD","LU1551013342.USD","LU2213496289.HKD","LU0471298777.SGD","LU0203202063.USD","LLYZ","LU0820561818.USD","LU2089984988.USD","LU2237443549.SGD","SG9999001176.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1868836914.USD","LU2471134879.HKD","LU1868836757.USD","ELIL","IE00BFSS8Q28.SGD","LU0316494557.USD","LU2023250504.SGD","LU2237443382.USD","LLYX","LU0058720904.USD","LU0256863902.USD","LU0466842654.USD","LU1548497426.USD","LU0823416689.USD","LU0683600562.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0234572021.USD","LU0823434740.USD","LU2552382132.HKD","IE00B2B36J28.USD","LU1868837300.USD","LU0114720955.EUR","LU1623119135.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0203201768.USD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU2111349929.HKD","LU2750360641.GBP","LU0198837287.USD","SG9999014914.USD","LU1988902786.USD","LU0882574055.USD","LU1804176565.USD","LU2264538146.SGD","LU0133085943.USD","LU0158827948.USD","LU2168563687.JPY","LU0225283273.USD","IE00BKDWB100.SGD","LU2360106947.USD","LU0256863811.USD","LU0882574139.USD","ELIS","LU1323610961.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU0823434583.USD","LU2237443978.SGD","LU2491050071.SGD","LU0122379950.USD","IE00BKPKM429.USD","LU2063271972.USD","LU2357305700.SGD","LU0943347566.SGD","AKTS","IE00B1XK9C88.USD","LU1974910355.USD","LU0353189763.USD","BK4533","LU2896262040.SGD","LU0417517546.SGD","LU1989771016.USD","LU2168564222.USD","IE00BN29S564.USD","LU0471298694.HKD","LU0964807845.USD","LU2361044949.HKD","SG9999013999.USD","SG9999014880.SGD","LU2417539215.USD","LU1093756325.SGD","LU0266013472.USD","LU0385154629.USD","LU1061106388.HKD","LU1291159041.SGD","SGXZ99366536.SGD","LU2089283258.USD","BK4585","LU2462157665.USD","LU1720051017.SGD","LU1057294990.SGD","LU0079474960.USD","LU2746668461.USD","LU0354030438.USD","IE0001KFT4U8.USD","LU0210536198.USD","IE00B7KXQ091.USD","LU0787776722.HKD","LU0158827781.USD","LU2456880835.USD","LU0109394709.USD","IE0009355771.USD","LU0689472784.USD","SG9999015952.SGD","LU2028103732.USD","LU0889565916.HKD","SGXZ81514606.USD","LU2023250330.USD","BK4599","LU0094547139.USD","BK4148","LU1023059063.AUD","IE0002141913.USD","LU0106261372.USD","LU2471134952.CNY","LU2236285917.USD","LU2237438978.USD","LU2491049909.HKD","LU2168564495.EUR","LU2237443465.HKD","LU0320765992.SGD","LU0820562030.AUD","LU2324357040.USD","LU2468319806.SGD","IE00BK4W5L77.USD","BK4007","LU1127390331.HKD","IE00BWXC8680.SGD","LU0320765059.SGD","LU1069344957.HKD","LU1093756168.USD","LU0672654240.SGD","LU2108987350.USD","LU2552382215.SGD","SG9999014898.SGD","LU0820561909.HKD","LU0109391861.USD","LU2471134796.USD","LU1629891620.HKD","IE00B4JS1V06.HKD","SG9999015986.USD","LU1712237335.SGD","LU1720051108.HKD","LU2211815571.USD","SGXZ57979304.SGD","BK4588","LU1917777945.USD","LU2106854487.HKD","IE0004445015.USD","IE0005OL40V9.USD","LU1366192091.USD","IE00BK4W5M84.HKD","LU2552382058.USD","LU0353189680.USD","BK4581","LLII","LU0354030511.USD","LU2361045086.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232655","title":"Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232655","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232655?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"Announced two-trial clinical development strategy for AKY-2519 enabling evaluation in multiple patient segmentsInitiated Phase 1b clinical trial of AKY-2519 in metastatic castration-resistant prostate","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292282/0/en/Aktis-Oncology-Reports-Financial-Results-and-Business-Highlights-for-First-Quarter-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS","BK4139","IND","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633336831","title":"Aktis Oncology to Present at the BofA Securities Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633336831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633336831?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068800,"startTime":"0","endTime":"0","summary":"BOSTON, May  06, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288736/0/en/Aktis-Oncology-to-Present-at-the-BofA-Securities-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4139","LABU","BK4585","BK4588","AKTS","XLV","XBI","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633942857","title":"Aktis Oncology Initiated at Buy on Differentiated Radiopharmaceutical Platform and mCRPC Opportunity for AKY‑2519","url":"https://stock-news.laohu8.com/highlight/detail?id=2633942857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633942857?lang=en_us&edition=fundamental","pubTime":"2026-05-05 23:45","pubTimestamp":1777995922,"startTime":"0","endTime":"0","summary":"William Blair analyst Alexandra Ramsey has reiterated their bullish stance on AKTS stock, giving a Buy rating on April 21. Alexandra Ramsey has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aktis-oncology-initiated-at-buy-on-differentiated-radiopharmaceutical-platform-and-mcrpc-opportunity-for-aky‑2519-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aktis-oncology-initiated-at-buy-on-differentiated-radiopharmaceutical-platform-and-mcrpc-opportunity-for-aky‑2519-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTS","BK4139","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633483910","title":"Aktis Oncology posts presentation outlining AKY-2519 Phase 1b clinical development strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633483910","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633483910?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:08","pubTimestamp":1777982909,"startTime":"0","endTime":"0","summary":"Aktis outlined a two-trial Phase 1b plan for AKY-2519, a B7-H3-targeted miniprotein radioconjugate, starting with a dedicated metastatic castration-resistant prostate cancer study.mCRPC Phase 1b has been initiated, with dose escalation using a BOIN design and expansion cohorts planned for PLUVICTO-naive patients plus PLUVICTO-experienced patients.Entry requires tumor uptake on imaging with [64Cu]Cu-AKY-2519, positioning trial to compare B7-H3 expression with PSMA expression.Imaging and dosimetry datasets are slated for presentation at ASCO 2026, with preliminary mCRPC Phase 1b data expected in 2027.Basket Phase 1b in B7-H3-expressing lung, colorectal, and other solid tumors is expected to start in 2H’26.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL9kqQfH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS","BK4148","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633896145","title":"Aktis Oncology initiates clinical trial of AKY-25191","url":"https://stock-news.laohu8.com/highlight/detail?id=2633896145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633896145?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:11","pubTimestamp":1777929108,"startTime":"0","endTime":"0","summary":"Aktis Oncology (AKTS) announced the initiation of a Phase 1b clinical trial of AKY-25191 in patients with metastatic castration-resistant prostate ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aktis-oncology-initiates-clinical-trial-of-aky-25191-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aktis-oncology-initiates-clinical-trial-of-aky-25191-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AKTS","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633963733","title":"Aktis Oncology Initiates Phase 1B Clinical Trial for Aky-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (Mcrpc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633963733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633963733?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:05","pubTimestamp":1777925100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA1X8LHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTS","BK4139","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631510860","title":"Aktis Oncology Initiated at Outperform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2631510860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631510860?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:42","pubTimestamp":1777470120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2026 09:42 ET (13:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631518289","title":"William Blair Initiates Aktis Oncology at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2631518289","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631518289?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:14","pubTimestamp":1777461248,"startTime":"0","endTime":"0","summary":"Aktis Oncology, Inc. (AKTS) has an average rating of buy and mean price target of $32.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629063666","title":"Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629063666","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629063666?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:00","pubTimestamp":1776805200,"startTime":"0","endTime":"0","summary":"AKY-2519, a miniprotein radioconjugate targeting B7-H3, to be featured in two poster presentationsData facilitate initial understanding of AKY-2519 biodistribution and predicted absorbed doses in tumo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278532/0/en/Aktis-Oncology-Announces-Presentation-of-First-Clinical-Imaging-and-Dosimetry-Data-for-AKY-2519-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BK4107","AKTS","BK4139","BK4117","IND","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628763734","title":"Aktis Oncology Board Shift And New Committee Draw Investor Focus On R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2628763734","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628763734?lang=en_us&edition=fundamental","pubTime":"2026-04-19 13:03","pubTimestamp":1776575011,"startTime":"0","endTime":"0","summary":"Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board.\nDr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee.\nThe company announced upcoming departures of two current Board members as part of this transition.\n\nAktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-akts/aktis-oncology/news/aktis-oncology-board-shift-and-new-committee-draw-investor-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-akts/aktis-oncology/news/aktis-oncology-board-shift-and-new-committee-draw-investor-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4148","AKTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628724622","title":"Aktis Oncology director Glenn Gormley files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628724622?lang=en_us&edition=fundamental","pubTime":"2026-04-17 04:05","pubTimestamp":1776369958,"startTime":"0","endTime":"0","summary":"Aktis Oncology filed an initial Form 3 for director Glenn Gormley dated April 15, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLbHbhz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTS","BK4139","BK4148"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":69,"code":"91000000","status":"200"}]}}